Dr Terry Lim is a member of the Translational Antigen Discovery Research group in the Centre for Cancer Research.
Areas of interest
Research group
Translational Antigen Discovery
Biography
Dr Terry Lim holds joint appointments, as a Senior Research Scientist in Dr Pouya Faridi’s laboratory, and in the Monash Proteomics and Metabolomics Platform (MPMP) – Clinical Proteomics Node. He has an Honorary Research Appointment at Hudson Institute. With a major interest in precision oncology, Dr Lim leverages on his expertise in cutting-edge proteomics, phosphoproteomics and immunopeptidomics to advance and accelerate translational and clinical research in order to bring cure closer to the patients.
Dr Lim’s academic journey includes the successful completion of a Bachelor of Biotechnology degree with first-class Honours, with a specialisation in medical biotechnology. Subsequently, under the mentorship of Professor Anthony Purcell, Dr Lim pursued and obtained a PhD from Monash University, where he employed innovative mass spectrometry techniques in the field of proteomics and immunopeptidomics to gain valuable insights into the immunological aspects of the human leukocyte antigen (HLA)-B27 and its correlation with the development of Ankylosing Spondylitis, an autoimmune disease.
Driven by a deep interest in cancer biology, Dr Lim embarked on postdoctoral research in the laboratory of Professor Roger Daly. In this role, he focused on utilising patient derived tumour samples in the form of organoids (PDO) and xenografts (PDX). By employing phosphoproteomics techniques, Dr Lim aimed to unravel the intricate molecular changes occurring in pancreatic, brain, and breast cancer in order to identify novel biomarkers and therapeutic targets for personalised cancer treatments.
Publication highlights
